Religare Health Insurance (RHI) recognized as one of the Brands making Healthcare Accessible

New Delhi: Religare Health Insurance (RHI), one of India’s leading Standalone Health Insurers was awarded ‘Health Access Brand’ at the Indian Health & Wellness Awards, 2018 for its product‘Grameen Care’ & its contribution towards achieving the vision of a healthy India.

‘Grameen Care’ reflects the organization’s endeavor to ensure that low & middle income group citizenry residing in tier-3 & rural markets have access to an affordable health insurance coverage which safeguards them against financial burden from any health adversity.

RHI’s initiative was not limited to product development but extended to identification & training healthcare centers at village/tehsil level to render cashless services to customers – a first-time experience for many beneficiaries.

Mr. Anuj Gulati, CEO and MD, Religare Health Insurance said, “The main strength of Grameen Care is that beneficiaries can avail cashless facility through a proximate network of able healthcare providers. It’s also specifically relevant as a credit protection instrument for customers of micro-finance institutions since it safeguards them from expenses arising out of a health adversity. We are pleased to have had successful implementation in key markets including Religare Health Insurance Himachal Pradesh, Jammu & Kashmir, among others. This award is recognition of the belief & faith our associates and customers repose in us.”

The organization has been adjudged the ‘Best Health Insurance Company’ at the ABP News-BFSI Awards & ‘Best Claims Service Leader of the Year – Insurance India Summit & Awards. Religare Health Insurance has also received the ‘Editor’s Choice Award for Best Product Innovation’ at Finnoviti and was conferred the ‘Best Medical Insurance Product Award’ at The FICCI Healthcare Awards.

Related Posts

Lilly launches Mounjaro KwikPen in India

Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

  Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines